| Literature DB >> 35048546 |
Hiroyuki Kuwano1,2, Takehiko Yokobori1,3, Munenori Ide4, Hiroshi Saeki1, Makoto Sohda1, Makoto Sakai1, Tomonori Yoshida1, Kengo Kuriyama1, Kyoichi Ogata1, Hiroomi Ogawa1, Takuhisa Okada1, Tatsuya Miyazaki5, Shunsuke Takahashi2, Ken Shirabe1.
Abstract
BACKGROUND & AIMS: Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) is a rare neuroendocrine neoplasm (NEN) comprising dual neuroendocrine and non-neuroendocrine components. Although the coexistence pattern of neuroendocrine and non-neuroendocrine components in definitive MiNEN is thought to overlap, there may be a coexistent pattern of both components, such as superficial carcinoma adjacent to NEN. The present study evaluated the histopathological findings of the coexistence pattern of superficial carcinomas adjacent to NENs in the esophagogastrointestinal tract.Entities:
Keywords: MiNEN; NEC; NET; bystander effect; neuroendocrine carcinoma
Mesh:
Year: 2022 PMID: 35048546 PMCID: PMC8855898 DOI: 10.1002/cam4.4485
Source DB: PubMed Journal: Cancer Med ISSN: 2045-7634 Impact factor: 4.452
Clinicopathologic characteristics of neuroendocrine neoplasm (esophagus)
| Case | Age/sex | Treatment | NEN | Adjacent coexistence of superficial carcinomatous area | ||||
|---|---|---|---|---|---|---|---|---|
| Diagnosis | pT | pN | M | pStage | ||||
| 1 | 67/M | Adjuvant chemotherapy, esophagectomy | Endocrine cell carcinoma | 3 | 2 | 0 | III | SCC |
| 2 | 72/M | Esophagectomy | Endocrine cell carcinoma | 2 | 1 | 0 | III | None |
| 3 | 59/M | Esophagectomy | Endocrine cell carcinoma | 3 | 1 | 0 | III | SCC |
| 4 | 66/F | Esophagectomy | Small‐cell neuroendocrine carcinoma | 1 | 1 | 0 | II | None |
| 5 | 76/M | Esophagectomy | Small‐cell neuroendocrine carcinoma | 1 | 0 | 0 | I | Intraepithelial squamous dysplasia |
| 6 | 57/M | Esophagectomy | Small‐cell neuroendocrine carcinoma | 1 | 0 | 0 | I | SCC |
| 7 | 63/F | Esophagectomy | Small‐cell neuroendocrine carcinoma | 1 | 0 | 0 | I | SCC |
| 8 | 70/M | Esophagectomy | Small‐cell neuroendocrine carcinoma | 1 | 0 | 0 | I | SCC |
| 9 | 80/M | Esophagectomy | Large‐cell neuroendocrine carcinoma | 3 | 3 | 0 | III | SCC |
| 10 | 51/M | Esophagectomy | Large‐cell neuroendocrine carcinoma | 1 | 1 | 0 | II |
Adenocarcinoma/dysplastic change of resident ducts. Atypia of resident grands and ducts. |
Abbreviations: NEN, neuroendocrine neoplasm; SCC, squamous cell carcinoma.
NEN case in an affiliation hospital.
FIGURE 1Histological distribution of NEN and adjacent SCC in a representative esophageal NEN sample. (A) Low‐ and (B) high‐power view of the tumor distribution of NEN and adjacent superficial SCC in a resected esophageal NEN sample. (C) Low‐ and (D) high‐power view of neural marker CD56 expression pattern of NEN and adjacent superficial SCC in a resected esophageal NEN sample. Red and black bars indicate 200 μm and 100 μm, respectively. NEN, neuroendocrine neoplasm; SCC, squamous cell carcinoma
Clinicopathologic characteristics of neuroendocrine neoplasm (stomach)
| Case | Age/sex | Treatment | NEN | Adjacent coexistence of superficial carcinomatous area | ||||
|---|---|---|---|---|---|---|---|---|
| Diagnosis | pT | pN | M | pStage | ||||
| 1 | 49/F | Gastrectomy | NET (G2) | 2 | 0 | 0 | II | None |
| 2 | 84/M | Gastrectomy | NET (G3) | 3 | 2 | 0 | III | Adenocarcinoma |
| 3 | 74/M | Gastrectomy | Large‐cell endocrine carcinoma | 2 | 0 | 0 | I | Adenocarcinoma |
| 4 | 73/M | Gastrectomy | NET (G3) | 1 | 3 | 1 | IV | Adenocarcinoma |
Abbreviations: NEN, neuroendocrine neoplasm; NET, neuroendocrine tumor.
NEN case in an affiliation hospital.
FIGURE 2Histological distribution of NEN and adjacent gastric adenocarcinoma in a representative gastric NEN sample. (A) Low‐ and (B) high‐power view of tumor distribution of NEN and adjacent superficial gastric adenocarcinoma in a resected gastric NEN sample. (C) Low‐ and (D) high‐power view of neural marker CD56 expression pattern of NEN and adjacent gastric adenocarcinoma in a resected gastric NEN sample. Red and black bars indicate 200 μm and 100 μm, respectively. NEN, neuroendocrine neoplasm
Clinicopathological characteristics of neuroendocrine neoplasm (colon and rectum)
| Case | Age/sex | Location | Treatment | NEN | Adjacent coexistence of superficial carcinomatous area | ||||
|---|---|---|---|---|---|---|---|---|---|
| Diagnosis | pT | pN | M | pStage | |||||
| 1 | 62/F | Ascending colon | Colectomy | Large‐cell neuroendocrine carcinoma | 4 | 2 | 1 | IV | Adenocarcinoma |
| 2 | 69/F | Transverse colon | Colectomy | Large‐cell neuroendocrine carcinoma | 4 | 2 | 1 | IV | Adenocarcinoma |
| 3 | 62/M | Sigmoid colon | Colectomy | Large‐cell neuroendocrine carcinoma | 4 | 1 | 1 | IV | Adenocarcinoma |
| 4 | 55/F | Rectum | Endoscopic mucosal resection | NET (G1) | 1 | X | 0 | I | None |
| 5 | 77/M | Rectum | Endoscopic mucosal resection | NET (G2) | 1 | X | 0 | I | None |
| 6 | 38/M | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | None |
| 7 | 50/F | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | None |
| 8 | 52/M | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | None |
| 9 | 60/M | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | None |
| 10 | 63/F | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | None |
| 11 | 66/M | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | None |
| 12 | 77/F | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | None |
| 13 | 82/M | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | None |
| 14 | 41/M | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | Adenocarcinoma |
| 15 | 43/M | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | Adenocarcinoma |
| 16 | 53/F | Rectum | Transanal resection | NET (G1) | 1 | X | 0 | I | Adenocarcinoma |
| 17 | 54/M | Rectum | Transanal resection | NET (G1) | 1 | X | 1 | IV | None: Adenocarcinoma (a little away) |
| 18 | 74/M | Rectum | Low anterior resection | NET (G1) | 2 | 1 | 0 | III | None |
| 19 | 72/M | Rectum | Low anterior resection | NET (G1) | 2 | 1 | 0 | III | None: Adenocarcinoma in adenoma (a little away) |
| 20 | 44/F | Rectum | Low anterior resection | NET (G2) | 1 | 1 | 0 | III | None: adenocarcinoma (a little away) |
| 21 | 57/M | Rectum | Low anterior resection | NET (G2) | 2 | 0 | 0 | I | None |
| 22 | 43/F | Rectum | Low anterior resection | NET (G2) | 3 | 1 | 1 | IV | None |
| 23 | 80/M | Rectum | Hartmann's operation | MiNEN | 3 | 1 | 1 | IV | None |
Abbreviations: MiNEN, mixed neuroendocrine–non‐neuroendocrine neoplasm; NEN, neuroendocrine neoplasm; NET, neuroendocrine tumor.
FIGURE 3Histological distribution of NEN and adjacent colon adenocarcinoma in a representative colon NEN sample. (A) Low‐ and (B) high‐power view of the tumor distribution of NEN and colon adenocarcinoma in a resected colon NEN sample (case 1 in Table 3). (C) Low‐ and (D) high‐power view of the neural marker synaptophysin expression pattern of NEN and adjacent colon adenocarcinoma in a resected colon NEN sample. Red and black bars indicate 200 μm and 100 μm, respectively. NEN, neuroendocrine neoplasm
FIGURE 4Histological transformation of resident ducts/glands in a representative esophageal NEN sample. (A) NEN‐adjacent dysplasia of ducts in a resected esophageal NEN sample (in the esophagogastric junction, the NEN tumor invades submucosa) (case 10 in Table 1). (B), (C) High‐power view of NEN‐adjacent transformation of resident ducts in a resected esophageal NEN sample. (D) NEN‐adjacent atypia of resident glands and ducts in a resected esophageal NEN sample. Black bar indicates 100 μm. NEN, neuroendocrine neoplasm